title: Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality.
authors.affiliation: Center for Medical Biometry and Medical Informatics, Institute for Medical Biometry and Statistics, Medical Center, University of Freiburg, Freiburg, 79104, Germany. Electronic address: wolke@imbi.uni-freiburg.de.
authors.forename: Martin
authors.initials: M
authors.lastname: Wolkewitz
authors.affiliation: Center for Medical Biometry and Medical Informatics, Institute for Medical Biometry and Statistics, Medical Center, University of Freiburg, Freiburg, 79104, Germany.
authors.forename: Martin
authors.initials: M
authors.lastname: Schumacher
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000188:drug therapy*; D008297:Male; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D053139:Oseltamivir / Q000627:therapeutic use*; D058873:Pandemics; D053243:Zanamivir / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir